Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Sham Stimulation + Task instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with Schizophrenia, Schizophreniform Disorder, or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Lumateperone with placebo for people with Schizophrenia or Schizo Affective Disorder. Participants receive Lumateperone or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1 or Schizo Affective Disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Closed-loop auditory stimulation can help people with Schizophrenia. Participants take part in Closed-loop auditory stimulation and complete follow-up assessments.
This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether questionnaires and follow-up can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether questionnaires and follow-up can help people with Psychiatric Diagnosis, Schizophrenia Disorders, or Psychological Trauma, Historical. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This observational study is following people with Schizophrenia or Schizo Affective Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at identify novel markers of psychosis using electroencephalography (EEG) for people with Schizophrenia Disorders, bipolarity, or Schizo Affective Disorder. Taking part may give some people access to EEG measure of visual processing, but direct benefit is not guaranteed.
This observational study is following people with Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Recorded interview can help people with First-episode Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Autism-Related Irritability. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
This study is comparing N-Acetylcysteine with placebo for people with Prodromal Schizophrenia. Participants receive N-Acetylcysteine or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Psychosis, Schizophrenia, At-risk Mental State, or Language Disorders. Some participants may receive healthy controls instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Paliperidone Palmitate Injection (3M) can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Controls instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia or Sensory Processing Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether NMDAE can help people with Schizophrenia. Participants take part in NMDAE and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia Spectrum Disorder. Some participants may receive PFC sham instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing NMDAE with placebo for people with Prodromal Schizophrenia. Participants receive NMDAE or placebo and complete study visits and assessments.
This study is looking at how safe and effective KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD is for people with Alzheimer Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.